Veriheal

MAY 26, 2022

Cannabis Advocacy With a Digital Twist. Much like RoC, patient advocacy is at the forefront of Veriheal’s work, which includes connecting patients with medical marijuana (MMJ) doctors, collecting patient data to improve future treatment, and battling harmful cannabis stigmas with education.

Advocacy 96

Advocacy Patients Clinical Trials Education 96

SpeedWeed

SEPTEMBER 17, 2021

Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. The millions of people afflicted with PTSD may soon have access to MDMA therapy, and we believe the millions suffering from TBI may experience similar relief in the future.”.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Cannabis Law Report

JANUARY 12, 2022

The Maya platform empowers psychedelic researchers, providers, and participants to collectively chart psychedelic best practices. The National Psychedelics Association is a non-profit advancing equitable access to safe psychedelic-assisted therapies through awareness, advocacy, and education.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Maha was the founder and president of UCLA’s first registered cannabis student group, Cannaclub.

Research and Development 117

Research and Development Education Agriculture Patients 117

The Cannigma

DECEMBER 12, 2022

Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

JUNE 10, 2021

An alternative approach to study relationships between marijuana policies and driving after marijuana use is to use surveys that collect information on self-reported behaviors and attitudes. 9-tetrahydrocannabinol on driving performance: a randomized clinical trial. Article Google Scholar. Effect of cannabidiol and ?9-tetrahydrocannabinol

Policy 59

Policy Safety Marijuana Data 59

Cannabis Law Report

SEPTEMBER 21, 2021

He also is a member of the Board of Directors at the Bend Chamber of Commerce and the Chamber’s Advocacy Committee. He also serves as the president of the Oregon Business Collective, a coalition of cannabis entities. Yes, pharmaceutical and adult-use retail cannabis are two completely different markets and user groups.

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52